MORE PROGRESS IN CANCER RESEARCH AT #ASCO18

  • daratumomab (Darzalex), a monoclonal antibody, with carfilzomib (Kyrpolis) a targeted therapy that inhibits a type of protein called proteasome that plays an important role in cell growth and programmed cell death;
  • venetoclax, a therapy that blocks BCL-2, a protein that prevents cell death, a necessary process that rids the body of damaged cells, combined with carfilzomib and dexamethasone.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society

964 Followers

The Leukemia & Lymphoma Society (LLS) is dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.